Skip to the page

Data / Form D filings / SYNAPSE BIOMEDICAL INC

SYNAPSE BIOMEDICAL INC: Form D filings

SYNAPSE BIOMEDICAL INC, a biotechnology company in Oberlin, OH, filed 2 Form D notices with the SEC between 2010 and 2022. The latest, on December 20, 2022, reports an offering of $809,998 with nothing sold yet.

Find out what SYNAPSE BIOMEDICAL INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
300 ARTINO STREET, Oberlin, OH, 44074
Phone
(440) 774-2488
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
$5,000,001 - $25,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1273829

The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 20, 2022New notice$809,998$0$809,9980Yet to occursec.gov
Jan 15, 2010New notice$1,221,882$433,358$788,5245Dec 31, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Anthony R IgnagniExecutive Officer, Director
Kiyotaka P MoriDirector
Moustapha P DiopExecutive Officer, Director
Raymond P OndersDirector
John P KrystowskiDirector

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Dec 19, 2022 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what SYNAPSE BIOMEDICAL INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.